ArticleProceedings of the ... Design of Medical Devices Conference. Design of Medical Devices Conference2026
A BENCHTOP PLATFORM FOR EVALUATING SEPTOSTOMY IN AORTIC DISSECTION.
Article in Proceedings of the ... Design of Medical Devices Conference. Design of Medical Devices Conference, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Aortic dissection is a major aortic catastrophe associated with significant morbidity and mortality. While Thoracic Endovascular Aortic Repair (TEVAR) is the standard treatment for chronic type B aortic dissection cases, a persistent fibrotic septum often prevents complete false lumen exclusion, leading to continued pressurization and treatment failure. Endovascular septostomy is increasingly explored as an adjunctive therapy to modify this septum and promote aortic remodeling. However, current techniques carry risks such as embolic debris generation, thermal injury, and unpredictable tearing, complications that are difficult to quantify or even detect in vivo. To address these limitations, we developed a benchtop platform designed to evaluate septostomy strategies under controlled, physiologically relevant conditions. A model dissected aorta with a representative septum is integrated into a pulsatile flow loop equipped with pressure and flow sensors, thermometry, and filtration to capture debris. This setup enables the precise measurement of hemodynamic changes, thermal effects, and embolic burden, alongside visual assessment of procedural efficacy. By creating a setup that mimics physiological conditions, this platform enables the direct comparison of different septostomy methods and supports the development of improved endovascular devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.